BEGIN:VCALENDAR
PRODID:-//planitpurple.northwestern.edu//iCalendar Event//EN
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
CLASS:PUBLIC
BEGIN:VTIMEZONE
TZID:America/Chicago
TZURL:http://tzurl.org/zoneinfo-outlook/America/Chicago
X-LIC-LOCATION:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SEQUENCE:0
DTSTART;TZID=America/Chicago:20250515T133000
DTEND;TZID=America/Chicago:20250515T143000
DTSTAMP:20250417T000000
SUMMARY:Special Lecture: Complex In Vitro Systems To Study Neurovascular Function In Health And Disease - Roger Kamm\, MIT
UID:628807@northwestern.edu
TZID:America/Chicago
DESCRIPTION:1:30pm on Thursday\, May 15 @ Ryan Hall Room 4003\, Evanston Campus  In-Person Only\, Refreshments Provided  Prof. Kamm is the Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering at the Massachusetts Institute of Technology  With our aging population\, neurodegenerative diseases are on the rise\, far outpacing increases in other common diseases. Recent advances from the pharmaceutical industry have produced new drugs capable of reducing the rate of decline in patients with Alzheimer’s disease with many more in the drug development pipeline. This\, combined with improved understanding of the factors that influence a variety of neurodegenerative diseases\, has given rise to increased interest both in the delivery of drugs to the brain and their efficacy in alleviating symptoms or preventing disease progression. Innovative in vitro platforms are needed to explore novel modalities of drug delivery to the brain and enable pharmaceutical companies to screen for new therapeutics.  In this presentation\, neurovascular models will be presented that recapitulate in vivo morphology and function and can be used both to quantify transport across the blood-brain barrier and replicate their effects in models of neurological and neurodegenerative diseases.   About Roger Kamm  Professor Kamm began his career at Northwestern University earning a degree in Mechanical Engineering. He subsequently earned both a master’s and a PhD in Mechanical Engineering at MIT. Since 1978\, he has been a professor of Mechanical Engineering at MIT. Professor Kamm was one of the founding members of the Biological Engineering Department when it was created in 1998. Kamm’s research focuses on problems at the interface of biology and mechanics\, formerly in cell and molecular mechanics\, and now in complex in vitro systems.  Current interests are in developing models of healthy and diseased organ function using microfluidic technologies\, with a focus on vascularization\, cancer and neurological disease.  Kamm is a member of the National Academies of Medicine and Engineering. He is co-founder of AIM Biotech\, a manufacturer of microfluidic systems for 3D culture.
LOCATION:Ryan Hall\, 4003\, 2190 Campus Drive\, Evanston\, IL 60208
TRANSP:OPAQUE
URL:
CREATED:20250417T000000
STATUS:CONFIRMED
LAST-MODIFIED:19691231T180000
PRIORITY:0
BEGIN:VALARM
TRIGGER:-PT10M
ACTION:DISPLAY
DESCRIPTION:Reminder
END:VALARM
END:VEVENT
END:VCALENDAR